Skip to content
Search

Latest Stories

India and UK institutes will lead fight against superbugs

Pharma chief Dr Yusuf Hamied backs lord Darzi's anti-microbial resistance project

India and UK institutes will lead fight against superbugs
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines (Photo: iStock)

THE philanthropist, Yusuf Hamied, has said he is supporting the setting up of a Fleming Institute in London – and in India – to combat Anti-Microbial Resistance (AMR), the problem that leads to “superbugs” in hospitals.

Dr Hamied, the chairman of the Indian pharma giant Cipla, is backing Lord Ara Darzi, of Imperial College London, in the fight against AMR.


He said he also has the “blessings” of Dame Sally Davies, master of Trinity College, Cambridge, recognised as one of the world’s leading AMR authorities.

According to the World Health Organisation (WHO), “AMR threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

“AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.

Speaking to Eastern Eye, Hamied set out the extent of the global problem: “Everyone in the medical profession, the (UK) government and all of us are seeing the enormity of the problem caused by AMR. Sally Davies and others have announced in the past that at least 10 million people will die over the next decade due to AMR.

“I have been involved in AMR for a number of years. Originally, it was through Dame Sally Davies.”

Lord Ara Darzi

Dame Sally, the chief medical officer for England and chief medical adviser to the UK government from March 2011 to September 2019, is the UK special envoy on AMR. She co-led a global campaign to bring the issue of AMR to the 71st UN General Assembly in New York, leading to 193 countries agreeing the landmark 2016 political declaration on AMR.

Hamied added: “Following up from this, earlier this year for the first time I met Lord Ara Darzi and we got on very well. And one of the functions that Imperial College and Lord Darzi want to take up is to set up, at the site of St Mary’s Hospital in Paddington, the Fleming Institute. It is named after Alexander Fleming, who discovered/ invented penicillin way back in 1928.”

Professor Darzi holds the Paul Hamlyn chair of surgery at Imperial College London, the Royal Marsden Hospital and the Institute of Cancer Research. He is also director of the Institute of Global Health Innovation at Imperial College. Research led by Darzi is aimed at achieving best surgical practice through innovation in surgery and enhancing patient safety and the quality of healthcare.

The WHO states: “Anti-microbials – including antibiotics, antivirals, antifungals and anti-parasitics – are medicines used to prevent and treat infections in humans, animals and plants. Micro-organisms that develop anti-microbial resistance are sometimes referred to as ‘superbugs’.

“It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.

“The misuse and overuse of antimicrobials in humans, animals and plants are the main drivers in the development of drug-resistant pathogens.

Dame Sally Davies

“AMR affects countries in all regions and at all income levels. Its drivers and consequences are exacerbated by poverty and inequality, and low- and middle-income countries are most affected.

“It puts many of the gains of modern medicine at risk. It makes infections harder to treat and makes other medical procedures and treatments – such as surgery, caesarean sections and cancer chemotherapy – much riskier.

“There is an inadequate research and development pipeline in the face of rising levels of resistance, and urgent need for additional measures to ensure equitable access to new and existing vaccines, diagnostics and medicines.

“In addition to death and disability, AMR has significant economic costs. The World Bank estimates that AMR could result in $1 trillion additional healthcare costs by 2050, and $1tr-$3.4tr gross domestic product losses per year by 2030.”

The problem of AMR is particularly acute in India. According to the National Library of Medicine in America, “the emergence and rapid spread of AMR pose a grave threat to public health globally, and particularly so in India. With its unique combination of a dense population, a significant disease burden, and diverse healthcare practices, India stands at a critical juncture in the global battle against AMR.

“AMR is a crisis within the Indian healthcare system as it severely hampers the effective treatment of infectious diseases, leading to higher mortality rates, longer hospital stays, and increased healthcare costs. Its rise could mark the return of the pre-antibiotic era, where common infections and minor surgeries could once again become life-threatening.”

This is an important reason why Hamied wants the Fleming Institute in London – he has visited the site by a canal in Paddington where it will be built with “the blessings” of the UK government – to have an Indian counterpart.

He said: “What we require is the Fleming Institute to develop a few things, such as newer antibiotics for the resistant strains of bacteria that have developed resistance to the current antibiotics. Also stop the misuse of antibiotics and see that the existing antibiotics that work are used effectively.

“All this activity will be done here in London at the Fleming Institute, hopefully under Lord Ara Darzi and with the blessings of Dame Sally Davies.

“My personal interest in this was that at a very early stage, in my talks with Lord Darzi, the suggestion came up that India needs a Fleming Institute as one-fourth of the world’s population is in India.

“And India is a major centre for the misuse and excessive use, particularly of anti-microbial agents, including antibiotics.

Dr Yusuf Hamied

“On this basis, we will cooperate with the Fleming Institute here and set up a suitable establishment in India which can work hand in glove with the Fleming institute that is being set up in London.

“On a personal basis, I will support the Fleming Institute here in London. The Indian counterpart would be funded by Indian philanthropists.

“One cannot today predict the cost of the establishment in the UK, or the running expenses. But I know they are planning in the region of £100 million as the cost here.

“It is early days regarding the Indian counterpart. But the cost of not taking an active interest in tackling AMR worldwide is much more than the cost of trying to tackle the problem.”

He said the problem in India is not simply one of doctors overprescribing antibiotics, but also patients demanding them: “They tell the doctor, ‘I’m not feeling well, please give me an antibiotic.’ They want to get well faster. And they all think that by taking an antibiotic, you can get well faster.”

More For You

Apollo-BCCI

The Board of Control for Cricket in India (BCCI) said the new contract with Apollo Tyres runs until March 2028. (Photo: BCCI)

Apollo Tyres replaces Dream11 as Team India’s lead sponsor until 2028

INDIAN cricket has signed Apollo Tyres as its new lead sponsor after fantasy sports platform Dream11 ended its contract following a government ban on online gambling.

The men's team travelled to the United Arab Emirates for the ongoing Asia Cup without a sponsor on their shirts after Dream11 exited the deal, which was worth about $44 million and was set to run until 2026.

Keep ReadingShow less
Sydney Sweeney

Filming is tentatively planned for early 2026

Getty Images

Sydney Sweeney offered £45m to star in big-budget Bollywood film

Highlights:

  • Sydney Sweeney reportedly offered £45m for a leading role in a major Bollywood film
  • The package includes £35m in fees and £10M in sponsorship deals
  • Filming is tentatively planned for early 2026 across New York, Paris, London, and Dubai
  • The project could make Sweeney one of the highest-paid Hollywood stars to join Indian cinema

A record-breaking offer

Hollywood actor Sydney Sweeney has reportedly been approached with a staggering £45M deal to star in one of the most expensive Bollywood films ever produced.

The 28-year-old Euphoria and The White Lotus star is said to have been offered £35m in fees plus an additional £10m through sponsorship agreements.

Keep ReadingShow less
Toshi.bet: Revolutionizing Crypto Gaming with High Rewards and Innovative Gameplay

Toshi.bet: Revolutionizing Crypto Gaming with High Rewards and Innovative Gameplay

Introduction

In the rapidly evolving world of crypto casinos, one platform is standing out for its innovative gameplay, unmatched rewards, and community-driven growth — Toshi.bet. Recognized by CoinMarketCap as a pioneer in crypto gaming, Toshi.bet is transforming how players interact with digital assets while gaming.

Why Toshi.bet Is Leading the Crypto Casino Industry

1. Best Rewards in Crypto Gaming

Keep ReadingShow less
China Nvidia chip ban

Nvidia boss Jensen Huang has said he is “disappointed” following reports

iStock

China reportedly bans Nvidia chip sales as CEO expresses disappointment

Highlights:

  • China’s Cyberspace Administration has reportedly ordered tech firms to stop using Nvidia’s AI chips
  • Nvidia CEO Jensen Huang says he is “disappointed” but will remain “patient”
  • Huang is visiting the UK alongside other tech leaders during Donald Trump’s state visit
  • Nvidia became the world’s first $4tn company earlier in 2025 amid the AI boom

Huang responds to reported China directive

Nvidia boss Jensen Huang has said he is “disappointed” following reports that China has told its leading technology firms to halt purchases of the company’s artificial intelligence chips.

Speaking to reporters in the UK, Huang added that he would remain “patient” in light of the reported order from China’s internet regulator, the Cyberspace Administration. “There are a lot of places we can’t go to, and that’s fine,” he said.

Keep ReadingShow less
Tagenarine Chanderpaul,

Tagenarine Chanderpaul. (Photo by PAT HOELSCHER/AFP via Getty Images)

Chanderpaul, Athanaze return as West Indies name squad for India tour

BATSMEN Tagenarine Chanderpaul and Alick Athanaze were recalled to the West Indies ranks when they were named in the squad to tour India on Tuesday (16) while left-arm spinner Khary Pierre is included for the first time.

The two-Test series, with matches in Ahmedabad and Delhi, marks the West Indies' first tour to India since 2018 and forms part of the World Test Championship.

Keep ReadingShow less